2013 Toyota Yaris on 2040-cars

Auto blog

Toyota prices fuel cell sedan $70K in Japan, coming to US and Europe next summer [w/video]

Toyota has finally unveiled its FCV hydrogen fuel cell sedan and its Japanese price. We won't have to wait too long to see the first of these revolutionary vehicles on the roads. It will go on sale in Japan in April 2015 and will come to the US and Europe later that summer.
In Japan, the FCV will be priced at roughly 7 million yen before taxes ($68,810 at current exchange rates). However, Toyota makes it clear in the press release that we shouldn't try to extrapolate US MSRP from that figure, saying that official pricing for the US and Europe has not yet been determined. As will be the case in the US, sales in Japan will be limited to parts of the country that already have a hydrogen refueling infrastructure (that means you, California).
The production version of the FCV looks almost identical to the concept from last year's Tokyo Motor Show. There is a new vertical strip of LEDs at each corner of the front air intake and real sideview windows, instead of the nubs on the prototype. The weird squiggles from the rear trim are also gone in favor of a more production-ready look, but the taillights survive the changes mostly intact.

Toyota wants improved crash scores with midcycle facelifts

The performances of some Toyotas in the Insurance Institute for Highway Safety's (IIHS) regimen of crash tests leave something to be desired. Consider the small overlap frontal crash test: only six Toyota, Lexus and Scion vehicles have undergone the new test, yet all but one of them received a poor rating. Osama Nagata, CEO of Toyota Motor Engineering & Manufacturing North America Inc., says midcycle vehicle updates are in the works to address the safety issues brought to light by the IIHS test, Automotive News reports. He confirmed that the RAV4 is getting safety updates following its crash test performance last month, but he didn't name any other models.
All three Toyotas that were tested - 2013 RAV4, 2012-2013 Prius V, 2012-2013 Camry - received poor ratings. The 2007-2012 Lexus ES 350 and 2006-2013 IS 250/350 also received poor ratings. The only other Toyota Motor Corp. vehicle to score better than poor is the 2014 Scion TC. It received an acceptable rating in the small overlap frontal crash test and is the only recent vehicle in Toyota's line-up to get the IIHS Top Safety Pick+ rating.
The small overlap front crash test measures the safety of a car when its front left corner is strikes an object during an accident, bypassing traditional crumple zones, which deform in a way to protect passengers. In 2009, automakers were alerted to the forthcoming addition of the test, which was first implemented last year, IIHS spokesman Russ Rader says. They responded with differing intensity, he says, pointing out that Subaru and Honda started incorporating design changes early on so their cars would perform well in the tests.

Toyota maintains world's largest automaker crown, GM and VW close behind

Toyota still holds the title of World's Largest Automaker. The Japanese automaker ceded the claim to General Motors in 2011 following a series of natural and man-made disasters that stifled production in Asia. Production is back up to full speed and, coupled with the introduction of a new Camry midsize sedan, Toyota retook the title in 2012 and has so far been able to keep it by selling 2.43 million vehicles in the first quarter of 2013.
The race is still tight - General Motors reports sales of 2.36 million vehicles, earning it the second spot globally with Volkswagen's 2.27 million sales nabbing the German automaker third place. It's not all smooth sailing for Toyota, either, as the brand's first-quarter figures were down 2.2 percent when compared to last year. GM posted a 3.6-percent gain and VW managed a 5.1-percent gain over the same period.
Sales in China may be a deciding factor as to which automaker performs best in 2013. Toyota's figures were down 13 percent in China. Meanwhile, GM and VW are continuing their upward trajectories in the crucial Chinese market.